Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 10/2011

01.10.2011 | Article

Fungal infection in a patient with multiple sclerosis

verfasst von: D. Pisa, R. Alonso, L. Carrasco

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

Multiple sclerosis (MS) is a chronic, inflammatory disease of the central nervous system, whose causes are still unknown. We have proposed that MS, as well as some ophthalmologic diseases, are associated with fungal infection. In the present study, we closely monitored a patient with MS over a three-year period. Antibodies against different Candida spp. were detected in peripheral blood serum, although the titer of these antibodies fluctuated. The presence of fungal macromolecules, such as proteins, polysaccharides, and DNA, was also tested. In several sera samples, antigens related to C. famata were evidenced by the slot-blot test using a rabbit polyclonal antibody against these species, while high levels of β-1,3 glucan were detected with the commercial Fungitell assay. Despite the variations by sample, we concluded that all fungal macromolecules, that is, proteins, polysaccharides, and DNA, were present in blood from the MS patient which was analyzed. Several fungal species were identified using polymerase chain reaction (PCR) followed by sequencing. Antibodies against Candida spp. as well as C. famata-related antigens were also detected in cerebrospinal fluid (CSF). Our findings provide support for the notion that disseminated mycosis is present in this patient.
Literatur
1.
Zurück zum Zitat Richardson MD (2005) Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56(Suppl 1):i5–i11PubMedCrossRef Richardson MD (2005) Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56(Suppl 1):i5–i11PubMedCrossRef
2.
Zurück zum Zitat White PL, Perry MD, Barnes RA (2009) An update on the molecular diagnosis of invasive fungal disease. FEMS Microbiol Lett 296(1):1–10PubMedCrossRef White PL, Perry MD, Barnes RA (2009) An update on the molecular diagnosis of invasive fungal disease. FEMS Microbiol Lett 296(1):1–10PubMedCrossRef
3.
Zurück zum Zitat De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46(12):1813–1821PubMedCrossRef De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46(12):1813–1821PubMedCrossRef
4.
Zurück zum Zitat Speth C, Rambach G, Würzner R, Lass-Flörl C (2008) Complement and fungal pathogens: an update. Mycoses 51(6):477–496PubMedCrossRef Speth C, Rambach G, Würzner R, Lass-Flörl C (2008) Complement and fungal pathogens: an update. Mycoses 51(6):477–496PubMedCrossRef
5.
Zurück zum Zitat Netea MG, Maródi L (2010) Innate immune mechanisms for recognition and uptake of Candida species. Trends Immunol 31(9):346–353PubMedCrossRef Netea MG, Maródi L (2010) Innate immune mechanisms for recognition and uptake of Candida species. Trends Immunol 31(9):346–353PubMedCrossRef
6.
Zurück zum Zitat Polonelli L, Casadevall A, Han Y, Bernardis F, Kirkland TN, Matthews RC, Adriani D, Boccanera M, Burnie JP, Cassone A, Conti S, Cutler JE, Frazzi R, Gregory C, Hodgetts S, Illidge C, Magliani W, Rigg G, Santoni G (2000) The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med Mycol 38(Suppl 1):281–292PubMed Polonelli L, Casadevall A, Han Y, Bernardis F, Kirkland TN, Matthews RC, Adriani D, Boccanera M, Burnie JP, Cassone A, Conti S, Cutler JE, Frazzi R, Gregory C, Hodgetts S, Illidge C, Magliani W, Rigg G, Santoni G (2000) The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med Mycol 38(Suppl 1):281–292PubMed
7.
Zurück zum Zitat Richardson M, Rautemaa R (2009) How the host fights against Candida infections. Front Biosci (Schol Ed) 1:246–257 Richardson M, Rautemaa R (2009) How the host fights against Candida infections. Front Biosci (Schol Ed) 1:246–257
8.
Zurück zum Zitat Romani L (1999) Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 2(4):363–367PubMedCrossRef Romani L (1999) Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 2(4):363–367PubMedCrossRef
9.
Zurück zum Zitat Zipfel PF, Würzner R, Skerka C (2007) Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 44(16):3850–3857PubMedCrossRef Zipfel PF, Würzner R, Skerka C (2007) Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 44(16):3850–3857PubMedCrossRef
10.
Zurück zum Zitat Chen SC, Halliday CL, Meyer W (2002) A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays. Med Mycol 40(4):333–357PubMed Chen SC, Halliday CL, Meyer W (2002) A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays. Med Mycol 40(4):333–357PubMed
11.
Zurück zum Zitat Bretagne S, Costa JM (2005) Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 45(3):361–368PubMedCrossRef Bretagne S, Costa JM (2005) Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 45(3):361–368PubMedCrossRef
12.
Zurück zum Zitat Montagna MT, Caggiano G, Borghi E, Morace G (2009) The role of the laboratory in the diagnosis of invasive candidiasis. Drugs 69(Suppl 1):59–63PubMedCrossRef Montagna MT, Caggiano G, Borghi E, Morace G (2009) The role of the laboratory in the diagnosis of invasive candidiasis. Drugs 69(Suppl 1):59–63PubMedCrossRef
13.
Zurück zum Zitat López-Ribot JL, Casanova M, Murgui A, Martínez JP (2004) Antibody response to Candida albicans cell wall antigens. FEMS Immunol Med Microbiol 41(3):187–196PubMedCrossRef López-Ribot JL, Casanova M, Murgui A, Martínez JP (2004) Antibody response to Candida albicans cell wall antigens. FEMS Immunol Med Microbiol 41(3):187–196PubMedCrossRef
14.
Zurück zum Zitat Pontón J (2009) Usefulness of biological markers in the diagnosis of invasive candidiasis. Rev Iberoam Micol 26(1):8–14PubMedCrossRef Pontón J (2009) Usefulness of biological markers in the diagnosis of invasive candidiasis. Rev Iberoam Micol 26(1):8–14PubMedCrossRef
15.
Zurück zum Zitat Ramos M, Pisa D, Molina S, Rábano A, Juarranz Á, Carrasco L (2008) Fungal infection in patients with multiple sclerosis. Open Mycol J 2:22–28CrossRef Ramos M, Pisa D, Molina S, Rábano A, Juarranz Á, Carrasco L (2008) Fungal infection in patients with multiple sclerosis. Open Mycol J 2:22–28CrossRef
16.
Zurück zum Zitat Carrasco L, Ramos M, Galisteo R, Pisa D, Fresno M, González ME (2005) Isolation of Candida famata from a patient with acute zonal occult outer retinopathy. J Clin Microbiol 43(2):635–640PubMedCrossRef Carrasco L, Ramos M, Galisteo R, Pisa D, Fresno M, González ME (2005) Isolation of Candida famata from a patient with acute zonal occult outer retinopathy. J Clin Microbiol 43(2):635–640PubMedCrossRef
17.
Zurück zum Zitat Pisa D, Ramos M, Molina S, García P, Carrasco L (2007) Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata. J Med Microbiol 56(Pt 5):571–578PubMedCrossRef Pisa D, Ramos M, Molina S, García P, Carrasco L (2007) Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata. J Med Microbiol 56(Pt 5):571–578PubMedCrossRef
18.
Zurück zum Zitat Pisa D, Ramos M, García P, Escoto R, Barraquer R, Molina S, Carrasco L (2008) Fungal infection in patients with serpiginous choroiditis or acute zonal occult outer retinopathy. J Clin Microbiol 46(1):130–135PubMedCrossRef Pisa D, Ramos M, García P, Escoto R, Barraquer R, Molina S, Carrasco L (2008) Fungal infection in patients with serpiginous choroiditis or acute zonal occult outer retinopathy. J Clin Microbiol 46(1):130–135PubMedCrossRef
19.
Zurück zum Zitat Jacobson DM (1996) Acute zonal occult outer retinopathy and central nervous system inflammation. J Neuroophthalmol 16(3):172–177PubMed Jacobson DM (1996) Acute zonal occult outer retinopathy and central nervous system inflammation. J Neuroophthalmol 16(3):172–177PubMed
20.
Zurück zum Zitat Weiner HL (2008) A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 255(Suppl 1):3–11PubMedCrossRef Weiner HL (2008) A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 255(Suppl 1):3–11PubMedCrossRef
21.
Zurück zum Zitat Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918–934PubMedCrossRef Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918–934PubMedCrossRef
22.
Zurück zum Zitat Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128(Pt 11):2705–2712PubMedCrossRef Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128(Pt 11):2705–2712PubMedCrossRef
23.
Zurück zum Zitat Barnett MH, Sutton I (2006) The pathology of multiple sclerosis: a paradigm shift. Curr Opin Neurol 19(3):242–247PubMedCrossRef Barnett MH, Sutton I (2006) The pathology of multiple sclerosis: a paradigm shift. Curr Opin Neurol 19(3):242–247PubMedCrossRef
24.
Zurück zum Zitat Gandhi R, Laroni A, Weiner HL (2010) Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 221(1–2):7–14PubMedCrossRef Gandhi R, Laroni A, Weiner HL (2010) Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 221(1–2):7–14PubMedCrossRef
25.
Zurück zum Zitat Venken K, Hellings N, Liblau R, Stinissen P (2010) Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol Med 16(2):58–68PubMedCrossRef Venken K, Hellings N, Liblau R, Stinissen P (2010) Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol Med 16(2):58–68PubMedCrossRef
26.
Zurück zum Zitat Sánchez-Portocarrero J, Pérez-Cecilia E, Corral O, Romero-Vivas J, Picazo JJ (2000) The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis 37(3):169–179PubMedCrossRef Sánchez-Portocarrero J, Pérez-Cecilia E, Corral O, Romero-Vivas J, Picazo JJ (2000) The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis 37(3):169–179PubMedCrossRef
27.
Zurück zum Zitat Benito-León J, Pisa D, Alonso R, Calleja P, Díaz-Sánchez M, Carrasco L (2010) Association between multiple sclerosis and Candida species: evidence from a case–control study. Eur J Clin Microbiol Infect Dis 29(9):1139–1145PubMedCrossRef Benito-León J, Pisa D, Alonso R, Calleja P, Díaz-Sánchez M, Carrasco L (2010) Association between multiple sclerosis and Candida species: evidence from a case–control study. Eur J Clin Microbiol Infect Dis 29(9):1139–1145PubMedCrossRef
28.
Zurück zum Zitat Pazos C, Pontón J, Del Palacio A (2005) Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43(1):299–305PubMedCrossRef Pazos C, Pontón J, Del Palacio A (2005) Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43(1):299–305PubMedCrossRef
29.
Zurück zum Zitat Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis—the plaque and its pathogenesis. N Engl J Med 354(9):942–955PubMedCrossRef Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis—the plaque and its pathogenesis. N Engl J Med 354(9):942–955PubMedCrossRef
30.
Zurück zum Zitat Santelmann H, Howard JM (2005) Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome. Eur J Gastroenterol Hepatol 17(1):21–26PubMedCrossRef Santelmann H, Howard JM (2005) Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome. Eur J Gastroenterol Hepatol 17(1):21–26PubMedCrossRef
31.
Zurück zum Zitat Gilden DH (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4(3):195–202PubMed Gilden DH (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4(3):195–202PubMed
32.
Zurück zum Zitat Giovannoni G, Cutter GR, Lunemann J, Martin R, Münz C, Sriram S, Steiner I, Hammerschlag MR, Gaydos CA (2006) Infectious causes of multiple sclerosis. Lancet Neurol 5(10):887–894PubMedCrossRef Giovannoni G, Cutter GR, Lunemann J, Martin R, Münz C, Sriram S, Steiner I, Hammerschlag MR, Gaydos CA (2006) Infectious causes of multiple sclerosis. Lancet Neurol 5(10):887–894PubMedCrossRef
33.
Zurück zum Zitat Khan ZU, Misra VC, Randhawa HS, Damodaran VN (1980) Pathogenicity of some ordinarily harmless yeasts for cortisone-treated mice. Sabouraudia 18(4):319–327PubMedCrossRef Khan ZU, Misra VC, Randhawa HS, Damodaran VN (1980) Pathogenicity of some ordinarily harmless yeasts for cortisone-treated mice. Sabouraudia 18(4):319–327PubMedCrossRef
34.
Zurück zum Zitat Procop GW, Roberts GD (2004) Emerging fungal diseases: the importance of the host. Clin Lab Med 24(3):691–719, vi–viiPubMedCrossRef Procop GW, Roberts GD (2004) Emerging fungal diseases: the importance of the host. Clin Lab Med 24(3):691–719, vi–viiPubMedCrossRef
35.
Zurück zum Zitat Brown MR, Thompson CA, Mohamed FM (2005) Systemic candidiasis in an apparently immunocompetent dog. J Vet Diagn Invest 17(3):272–276PubMedCrossRef Brown MR, Thompson CA, Mohamed FM (2005) Systemic candidiasis in an apparently immunocompetent dog. J Vet Diagn Invest 17(3):272–276PubMedCrossRef
36.
Zurück zum Zitat Lenard ZM, Lester NV, O’Hara AJ, Hopper BJ, Lester GD (2007) Disseminated cryptococcosis including osteomyelitis in a horse. Aust Vet J 85(1–2):51–55, quiz 85PubMedCrossRef Lenard ZM, Lester NV, O’Hara AJ, Hopper BJ, Lester GD (2007) Disseminated cryptococcosis including osteomyelitis in a horse. Aust Vet J 85(1–2):51–55, quiz 85PubMedCrossRef
37.
Zurück zum Zitat Purzycki CB, Shain DH (2010) Fungal toxins and multiple sclerosis: a compelling connection. Brain Res Bull 82(1–2):4–6PubMedCrossRef Purzycki CB, Shain DH (2010) Fungal toxins and multiple sclerosis: a compelling connection. Brain Res Bull 82(1–2):4–6PubMedCrossRef
38.
Zurück zum Zitat Ménard A, Amouri R, Dobránsky T, Charriaut-Marlangue C, Pierig R, Cifuentes-Diaz C, Ghandour S, Belliveau J, Gascan H, Hentati F, Lyon-Caen O, Perron H, Rieger F (1998) A gliotoxic factor and multiple sclerosis. J Neurol Sci 154(2):209–221PubMedCrossRef Ménard A, Amouri R, Dobránsky T, Charriaut-Marlangue C, Pierig R, Cifuentes-Diaz C, Ghandour S, Belliveau J, Gascan H, Hentati F, Lyon-Caen O, Perron H, Rieger F (1998) A gliotoxic factor and multiple sclerosis. J Neurol Sci 154(2):209–221PubMedCrossRef
39.
Zurück zum Zitat Pierig R, Belliveau J, Amouri R, Ménard A, Rieger F (2002) Association of a gliotoxic activity with active multiple sclerosis in US patients. Cell Mol Biol (Noisy-le-Grand) 48(2):199–203 Pierig R, Belliveau J, Amouri R, Ménard A, Rieger F (2002) Association of a gliotoxic activity with active multiple sclerosis in US patients. Cell Mol Biol (Noisy-le-Grand) 48(2):199–203
40.
Zurück zum Zitat Pacheco M, Pisa D, García-Gómez P, Carrasco L, Juarranz A (2007) Attachment and entry of Candida famata in monocytes and epithelial cells. Microsc Res Tech 70(11):975–986PubMedCrossRef Pacheco M, Pisa D, García-Gómez P, Carrasco L, Juarranz A (2007) Attachment and entry of Candida famata in monocytes and epithelial cells. Microsc Res Tech 70(11):975–986PubMedCrossRef
Metadaten
Titel
Fungal infection in a patient with multiple sclerosis
verfasst von
D. Pisa
R. Alonso
L. Carrasco
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2011
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1206-1

Weitere Artikel der Ausgabe 10/2011

European Journal of Clinical Microbiology & Infectious Diseases 10/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.